These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 3342468

  • 1. Antitumor effect of CPT-11, a new derivative of camptothecin, against pleiotropic drug-resistant tumors in vitro and in vivo.
    Tsuruo T, Matsuzaki T, Matsushita M, Saito H, Yokokura T.
    Cancer Chemother Pharmacol; 1988; 21(1):71-4. PubMed ID: 3342468
    [Abstract] [Full Text] [Related]

  • 2. Experimental antitumor activity and pharmacokinetics of the camptothecin analog irinotecan (CPT-11) in mice.
    Bissery MC, Vrignaud P, Lavelle F, Chabot GG.
    Anticancer Drugs; 1996 Jun; 7(4):437-60. PubMed ID: 8826613
    [Abstract] [Full Text] [Related]

  • 3. Reversal of multidrug resistance by a novel quinoline derivative, MS-209.
    Sato W, Fukazawa N, Nakanishi O, Baba M, Suzuki T, Yano O, Naito M, Tsuruo T.
    Cancer Chemother Pharmacol; 1995 Jun; 35(4):271-7. PubMed ID: 7828268
    [Abstract] [Full Text] [Related]

  • 4. Enhancement of vincristine- and adriamycin-induced cytotoxicity by verapamil in P388 leukemia and its sublines resistant to vincristine and adriamycin.
    Tsuruo T, Iida H, Yamashiro M, Tsukagoshi S, Sakurai Y.
    Biochem Pharmacol; 1982 Oct 01; 31(19):3138-40. PubMed ID: 7150340
    [Abstract] [Full Text] [Related]

  • 5. Reversal of multidrug resistance by an immunosuppressive agent FK-506.
    Naito M, Oh-hara T, Yamazaki A, Danki T, Tsuruo T.
    Cancer Chemother Pharmacol; 1992 Oct 01; 29(3):195-200. PubMed ID: 1370765
    [Abstract] [Full Text] [Related]

  • 6. A fluorine-containing anthracycline (ME2303) as a new antitumor agent against murine and human tumors and their multidrug-resistant sublines.
    Tsuruo T, Yusa K, Sudo Y, Takamori R, Sugimoto Y.
    Cancer Res; 1989 Oct 15; 49(20):5537-42. PubMed ID: 2790778
    [Abstract] [Full Text] [Related]

  • 7. In vivo antitumor activity of S 16020-2, a new olivacine derivative.
    Guilbaud N, Kraus-Berthier L, Saint-Dizier D, Rouillon MH, Jan M, Burbridge M, Visalli M, Bisagni E, Pierré A, Atassi G.
    Cancer Chemother Pharmacol; 1996 Oct 15; 38(6):513-21. PubMed ID: 8823492
    [Abstract] [Full Text] [Related]

  • 8. Circumvention of vincristine and Adriamycin resistance in vitro and in vivo by calcium influx blockers.
    Tsuruo T, Iida H, Nojiri M, Tsukagoshi S, Sakurai Y.
    Cancer Res; 1983 Jun 15; 43(6):2905-10. PubMed ID: 6850602
    [Abstract] [Full Text] [Related]

  • 9. Effects of quinidine and related compounds on cytotoxicity and cellular accumulation of vincristine and adriamycin in drug-resistant tumor cells.
    Tsuruo T, Iida H, Kitatani Y, Yokota K, Tsukagoshi S, Sakurai Y.
    Cancer Res; 1984 Oct 15; 44(10):4303-7. PubMed ID: 6467192
    [Abstract] [Full Text] [Related]

  • 10. Circumvention of multidrug resistance by a newly synthesized quinoline derivative, MS-073.
    Sato W, Fukazawa N, Suzuki T, Yusa K, Tsuruo T.
    Cancer Res; 1991 May 01; 51(9):2420-4. PubMed ID: 1673087
    [Abstract] [Full Text] [Related]

  • 11. Antitumor effect of DX-8951, a novel camptothecin analog, on human pancreatic tumor cells and their CPT-11-resistant variants cultured in vitro and xenografted into nude mice.
    Takiguchi S, Kumazawa E, Shimazoe T, Tohgo A, Kono A.
    Jpn J Cancer Res; 1997 Aug 01; 88(8):760-9. PubMed ID: 9330608
    [Abstract] [Full Text] [Related]

  • 12. Effect of homoharringtonine on the viability of murine leukemia P388 cells resistant to either adriamycin, vincristine, or 1-beta-D-arabinofuranosylcytosine.
    Wilkoff LJ, Dulmadge DA, Laster WR, Griswold DP.
    Cancer Chemother Pharmacol; 1989 Aug 01; 23(3):145-50. PubMed ID: 2924372
    [Abstract] [Full Text] [Related]

  • 13. [Study for modifying activity of solvents on antitumor activity of paclitaxel].
    Fujimoto S.
    Gan To Kagaku Ryoho; 1994 Apr 01; 21(5):665-70. PubMed ID: 7908793
    [Abstract] [Full Text] [Related]

  • 14. Acquired vs innate multidrug resistance and the effect of calcium channel blockers.
    Tsuruo T.
    Prog Clin Biol Res; 1986 Apr 01; 223():203-16. PubMed ID: 3468516
    [Abstract] [Full Text] [Related]

  • 15. A benzophenazine derivative, N-beta-dimethylaminoethyl 9-carboxy-5-hydroxy-10-methoxy-benzo[a]phenazine-6-carboxamide, as a new antitumor agent against multidrug-resistant and sensitive tumors.
    Tsuruo T, Naito M, Takamori R, Tsukahara S, Yamabe-Mitsuhashi J, Yamazaki A, Oh-hara T, Sudo Y, Nakaike S, Yamagishi T.
    Cancer Chemother Pharmacol; 1990 Apr 01; 26(2):83-7. PubMed ID: 2161296
    [Abstract] [Full Text] [Related]

  • 16. Reversal of multidrug resistance by novel nitrophenyl pyrones, SNF4435C and D.
    Kurosawa K, Takahashi K, Tsuda E, Tomida A, Tsuruo T.
    Jpn J Cancer Res; 2001 Nov 01; 92(11):1235-41. PubMed ID: 11714449
    [Abstract] [Full Text] [Related]

  • 17. [Reversal of acquired resistance to vinca alkaloids and anthracycline antibiotics by calcium channel blockers and calmodulin inhibitors].
    Tsuruo T.
    Gan To Kagaku Ryoho; 1984 Mar 01; 11(3 Pt 2):750-9. PubMed ID: 6585181
    [Abstract] [Full Text] [Related]

  • 18. Attenuation of cytogenetic effects by erythropoietin in human lymphocytes in vitro and P388 ascites tumor cells in vivo treated with irinotecan (CPT-11).
    Digkas E, Kareli D, Chrisafi S, Passadaki T, Mantadakis E, Hatzimichail A, Vargemezis V, Lialiaris T.
    Food Chem Toxicol; 2010 Jan 01; 48(1):242-9. PubMed ID: 19819285
    [Abstract] [Full Text] [Related]

  • 19. Reversal by two dihydropyridine compounds of resistance to multiple anticancer agents in mouse P388 leukemia in vivo and in vitro.
    Kiue A, Sano T, Naito A, Inada H, Suzuki K, Okumura M, Kikuchi J, Sato S, Takano H, Kohno K.
    Jpn J Cancer Res; 1990 Oct 01; 81(10):1057-64. PubMed ID: 1977728
    [Abstract] [Full Text] [Related]

  • 20. Potentiation of vincristine by vitamin A against drug-resistant mouse leukaemia cells.
    Nogae I, Kikuchi J, Yamaguchi T, Nakagawa M, Shiraishi N, Kuwano M.
    Br J Cancer; 1987 Sep 01; 56(3):267-72. PubMed ID: 3663474
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.